Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: NZ$3.5 M
• Last 3 months FTD volume: NZ$14.63 M
• Last year FTD volume: NZ$14.63 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	NZ$48.74 M	NZ$0.23 B	🇺🇸 USA
Alnylam Pharmaceuticals ALNY	NZ$10.34 M	NZ$44.1 M	🇺🇸 USA
Biogen BIIB	NZ$7.66 M	NZ$69.08 M	🇺🇸 USA
Johnson & Johnson JNJ	NZ$70.18 M	NZ$0.32 B	🇺🇸 USA
Novartis NVS	NZ$22.57 M	NZ$74.81 M	🇨🇭 Switzerland
Sanofi SNY	NZ$11.64 M	NZ$71.88 M	🇫🇷 France